Patients With Diabetes More Likely to Experience Adverse Financial Outcomes

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

MONDAY, July 28, 2025 -- Patients with type 2 diabetes may experience substantially more adverse financial outcomes compared with patients without diabetes, according to a study published online July 28 in JAMA Network Open.

Matthew Pesavento, Ph.D., from The Ohio State University in Columbus, and colleagues investigated the association of type 2 diabetes and adverse financial outcomes. The analysis included electronic health records linked to credit records for 166,285 adults with at least one medical encounter at a primary care medical center (from Oct. 1, 2017, to Dec. 31, 2021).

The researchers found that for patients with versus without diabetes, estimated probabilities were significantly higher for any adverse financial outcomes (64.5 versus 49.9 percent), below-prime credit scores (59.7 versus 45.9 percent), medical collections (36.9 versus 23.9 percent), nonmedical collections (38.4 versus 27.7 percent), delinquent debt (23.3 versus 15.6 percent), debt charge-offs (15.4 versus 10.1 percent), bankruptcy filings (2.1 versus 1.4 percent), and foreclosures (0.5 versus 0.3 percent). Overall, among patients of Black race, enrolled in Medicaid, of Hispanic ethnicity, younger than 65 years, without earned income, and of female sex, the adjusted prevalence of adverse financial outcomes was higher.

"This information also may inform holistic treatment approaches that might ease the financial vulnerability of individuals with diabetes," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-29 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords